Clinical Trial Update: Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral panobinostat in adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), either after stem cell transplant o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Panobinostat (Panobinostat)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2019-11-22